Rutgers University Genetics of Kidney Disease
Official title: The Rutgers University Study of the Genetics of Kidney Disease
Run by Rutgers, The State University of New Jersey · NCT07217535 · Data updated 2026-11-12
This project will see if genes are linked to kidney disease risk by collecting health surveys and saliva DNA from people 18 and older in the U.S.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50000 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Piscataway, New Jersey) |
| Status | Recruiting |
| Started | April 23, 2026 |
| Main results expected | October 31, 2028 |
| Study ends | October 31, 2028 |
| Registry record updated | April 24, 2026 |
| Trial ID | NCT07217535 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older living in the United States who can read English, have internet access, and are willing to provide a mailed saliva sample and complete health surveys are ideal candidates.
✕Probably not a fit
People under 18, those without internet access or unwilling to mail a saliva sample, and individuals seeking immediate medical treatment are unlikely to receive direct clinical benefits from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This online observational project collects health survey responses and a saliva sample mailed from participants to study genetic links to kidney disease. Participation takes about 20 minutes, requires internet access, and does not require an office visit or a kidney disease diagnosis. Participants may optionally share electronic health record data and can receive free genetic ancestry information. The investigators aim for a diverse U.S. participant group to improve the usefulness of the genetic data.
Why it matters
Potential benefit: If successful, the project could identify genetic factors that help improve diagnosis, risk prediction, and future drug development for kidney disease.
How similar studies have gone: Large population genomic projects have previously linked genetic variants to kidney function and related traits, so this approach builds on established methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18 years or older * currently living in the United States * able to understand and follow written instructions in English * have access to the internet and a computer, laptop, tablet or smart phone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home * willing to complete a survey with questions about health related to the study of kidney disease Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criter
Where it's running
-
Rutgers, The State University of New Jersey
Piscataway, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Tara Matise, Ph.D. — Rutgers, The State University of New Jersey
- Study coordinator: Tara Matise, Ph.D.
- Email: rugcc-kd@rutgers.edu
- Phone: 858-445-3125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of general vs spinal-epidural anesthesia on kidney transplant biomarkers
This study tests whether sevoflurane general anesthesia or combined spinal-epidural anesthesia changes markers of cellular stress and protective peptides in adults undergoing kidney transplantation.
-
AdiaVita regenerative therapy for chronic kidney disease
This trial tests whether AdiaVita (umbilical cord blood stem cells and exosomes plus glutathione) can improve kidney function in adults with stage 2–4 chronic kidney disease.
-
Long-term zigakibart treatment for adults with IgA nephropathy
Adults with IgA nephropathy who finished an earlier zigakibart trial will receive ongoing subcutaneous zigakibart every two weeks to see if it stays safe and helps over the long term.
-
New method for diagnosing acute rejection in kidney transplants
This study is testing a new way to diagnose acute rejection in kidney transplants by using a special test on urine to help tailor treatments for better recovery.
-
Pedal Pump Device for Lower Extremity Edema in Hospitalized Patients
This study tests a foot-pump device to see if it is tolerable and can help reduce swelling in the legs of hospitalized patients with edema.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.